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Background. The proteinuria selectivity index (SI) may be used
to describe changes of the glomerular permeability for macromol-
ecules in glomerular diseases. Proteins the size of a2-macroglob-
ulin (a2M) or IgM cannot normally pass the glomerular barrier,
whereas IgG can pass through the large pores of glomerular
basement membrane. Comparison of the clearance of the three
high-molecular-weight proteins to that of albumin may be useful
in characterization and diagnosis of different glomerular diseases
as well as in understanding of the permeability characteristics of
the glomerular filter.
Methods. Three types of SI, each calculated as a ratio of
clearance of either IgG, a2M or IgM to that of albumin, were
measured in 199 proteinuric patients. The patients were subdi-
vided into eight different biopsy-verified glomerular diseases.
Results. Two diagnoses could be clearly distinguished using SI
based on a2M (a2M SI) or IgM (IgM SI). Both a2M SI and IgM
SI were significantly lower in minimal change nephropathy and
higher in crescentic necrotizing glomerulonephritis than in all the
other diagnoses. The SI based on IgG (IgG SI) was less useful in
determining specific diagnoses, since patients with minimal
change nephropathy could not be distinguished from those with
other types of primary glomerulonephritis and patients with
crescentic necrotizing glomerulonephritis did not differ from
those with diabetic nephropathy.
Conclusions. The findings of this study indicate that a2M SI and
IgM SI are superior to IgG SI in characterization of glomerular
disorders and might replace the IgG SI for this purpose.
The proteinuria selectivity index (SI) has been used for
more than 30 years to describe changes of the glomerular
permeability for macromolecules in glomerular diseases
[1]. Based on a comparison of the clearance of high-
molecular-weight proteins to that of albumin, the pattern of
glomerular proteinuria may be described as either selective
or non-selective [2]. The protein usually used as the high-
molecular-weight marker is IgG, but others proteins such
as haptoglobin, cerruloplasmin, and a2-macroglobulin
(a2M) have also been used [3]. Patients with an IgG SI of
0.2 or higher are considered to have a non-selective pro-
teinuria whereas patients with a ratio below 0.2 are consid-
ered to have a selective proteinuria [4].
The concept of selectivity is based on our understanding
of the barrier function of the glomerular capillary wall.
According to the heteroporous membrane model, hypo-
thetical cylindrical pores having either a continuous distri-
bution of pore radii or consisting of two populations of
pores perforate the glomerular filter. The vast majority of
the pores in the latter model is composed of “small pores”
whereas the remaining pore population consists of a rela-
tively small number of “large pores” [5]. The small pore
presents a radius of 29 to 31 Å to negatively charged, rigid,
spherical proteins [6], whereas the large pore radius is
approximately 110 to 115 Å [7]. Consequently, transport of
proteins the size of albumin (67 kD molecular weight, mol
radius 36 Å) or IgG (150 kD molecular weight, mol radius
55 Å) occurs under normal conditions entirely through the
large pores. However, when the negative charge of the
glomerular capillary wall is lost, the effective small pore
radius towards negatively charged macromolecules in-
creases to 37 to 39 Å, allowing transport of albumin, but not
IgG, through the small pores. Very large macromolecules
like IgM (; 900 kD molecular weight, mol radius 120 Å)
will normally not pass the glomerular filter at all, and a2M
(720 kD molecular weight, mol radius 90 Å) will appear
only in extremely low concentrations in urine [7].
The most likely defect of glomeruli characteristic of
Key words: albuminuria, glomerular disease, immunoglobulin G, immu-
noglobulin M, permeability, clearance.
Received for publication November 24, 1997
and in revised form May 21, 1998
Accepted for publication July 1, 1998
© 1998 by the International Society of Nephrology
Kidney International, Vol. 54 (1998), pp. 2098–2105
2098
minimal change nephropathy is loss of the charge selectivity
of the glomerular capillary wall. As the size selectivity of
the glomerular capillary wall is intact, molecules the size of
IgG or larger are rejected while albumin is able to pass
through the small pores, resulting in a preferential albu-
minuria, that is, that proteinuria is highly selective [6, 8]. In
composite forms of glomerular inflammatory reactions,
such as in membranous glomerulonephritis or diffuse pro-
liferative glomerulonephritis, the loss of size selectivity and
perhaps also charge selectivity might explain the pattern of
non-selective proteinuria that is found in these diseases [6,
9, 10].
The present investigation compares the diagnostic poten-
tial of a2M SI and IgM SI to differentiate between various
glomerular disorders with that of IgG SI. The results
strongly indicate that both a2M SI and IgM SI are superior
to IgG SI for this type of diagnostic index.
METHODS
Patients
The patients in this study were participants in a large
investigation of all forms of glomerular disease currently
being conducted at the Department of Nephrology, Uni-
versity Hospital, Lund, Sweden for which the inclusion
criteria were the presence of nephrotic syndrome or at least
two of the following observations: hematuria, albumin
creatinine index (ACI) higher than 30 mg/mmol, patholog-
ical casts in urine sediment, impaired renal function. The
morphological diagnoses were established by evaluation by
light microscopy and immunofluorescent staining of repre-
sentative percutaneous renal biopsy specimens.
From a series of 462 patients investigated during the
period 1989 to 1995, 199 (133 males and 66 females)
patients with ACI higher than 30 mg/mmol and the diag-
nosis of either diffuse proliferative glomerulonephritis,
mesangial proliferative glomerulonephritis, IgA nephrop-
athy, membranous glomerulonephritis, crescentic necro-
tizing glomerulonephritis, minimal change nephropathy,
diabetes nephropathy or nephrosclerosis secondary to hy-
pertension were selected for participation in this study.
There was no age cut-off for inclusion in the series. Patients
with diagnoses other than those listed above or with
albuminuria lower than ACI of 30 mg/mmol were excluded
from the study. The number, age and sex distribution of
patients in the different diagnosis groups are presented in
Table 1, and some of the patients’ renal data are presented
in Table 2.
Laboratory methods
The blood samples and the first voided urine specimen
were obtained in the morning of the day the kidney biopsy
was performed. Measures of 30 ml of urine portions were
collected in polyethene vessels (Kebo AB, Sweden). The
samples were, after addition of one ml of a preservative
solution, kept frozen at 220°C until assayed. The preser-
vative solution, described in an earlier study [11], contained
benzamidinium chloride, EDTA, sodium azide and tris
base representing inhibitors of serine proteinases and met-
alloproteinases, an antimicrobial agent and a buffer sub-
stance, respectively. We have previously demonstrated that
all investigated proteins in urine samples stored at 220°C
result in stable levels using this procedure [11, 12].
Serum creatinine (SCr) and urinary creatinine (UCr) were
determined enzymatically using a Kodak Ektachem 700
XR-C system. Urinary albumin (UAlb), urinary IgG (UIgG),
and serum albumin (SAlb), serum IgG (SIgG), and serum
IgM (SIgM) were determined by immunoturbidimetry [13–
15] using a Cobas Mira S system (Roche Inc.) and mono-
specific rabbit antisera obtained from Dako (Copenhagen,
Denmark). The detection limits (the sensitivities) of the
methods for determination of the urine concentrations of
albumin and IgG were 1 and 5 mg/liter, respectively. The
coefficients of variation (intra-assay 1 interassay) for these
procedures varied with the concentration levels but were
between 3 and 8% for all levels. The procedures for
quantitation of serum and urine albumin, IgG, and creati-
nine were accredited by the Swedish Board for Accredita-
tion and Conformity Assessment (SWEDAC), and fulfilled
the requirements in SS-EN 45 001.
Table 1. Number, sex and mean age (range) of patients in different
diagnosis groups
Diagnosis Number
Males/Females
N/N
Age (range)
years
Diabetic nephropathy 18 9/9 59 (20–81)
Diffuse proliferative
glomerulonephritis
20 15/5 61 (32–80)
IgA nephropathy 24 20/4 40 (18–71)
Membranous glomerulonephritis 36 22/14 59 (20–82)
Mesangial proliferative
glomerulonephritis
37 23/14 49 (19–84)
Minimal change nephropathy 21 11/10 45 (12–80)
Necrotizing glomerulonephritis 29 20/9 57 (17–77)
Nephrosclerosis 14 13/1 59 (29–75)
Table 2. Means (ranges) of serum creatinine (SCr) albumin creatinine
index (ACI), and serum albumin (SAlb) in different diagnosis groups
Diagnosis
SCr
mmol/liter
ACI
mg/mmol
SAlb
g/liter
Diabetic nephropathy 221 (84–690) 375 (35–1026) 31 (21–42)
Diffuse proliferative
glomerulonephritis 204 (73–404) 318 (42–15323) 27 (11–38)
IgA nephropathy 151 (54–538) 241 (30–955) 35 (6–44)
Membranous
glomerulonephritis
132 (55–647) 465 (36–1223) 23 (11–43)
Mesangial proliferative
glomerulonephritis 108 (54–231) 210 (30–910) 30 (11–44)
Minimal change
nephropathy
108 (44–324) 615 (86–1402) 14 (7–29)
Necrotizing
glomerulonephritis
487 (101–1870) 193 (31–1238) 29 (19–37)
Nephrosclerosis 226 (75–936) 149 (64–585) 36 (24–42)
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Sa2M and Ua2M were determined by single radial immu-
nodiffusion test [16] using a monospecific rabbit antiserum
and calibrator from Dako. Aliquots of 8 ml of undiluted
plasma or urine were used and the plates were incubated in
a humid chamber at 8°C for ten days. The coefficient of
variation for the quantitative determinations was 5 to 10%
and the sensitivity of the method for quantitation of a2M
was 1.6 mg/liter.
UIgM was measured by a new enzyme-linked immunosor-
bent assay (ELISA) described below:
Step 1. Aliquots of 200 ml of a solution of sheep
immunoglobulins against human IgM (The Binding Site,
Birmingham, UK), diluted to 1 mg/liter were incubated in
96-well polystyrene microtiter plates (Nunc Immunoplate I;
Nunc, Roskilde, Denmark) overnight at 4°C. A dilution
buffer of 0.05 M Tris, 0.05 M sodium carbonate, 0.15 M NaCl,
0.002 M EDTA, pH 9.5 to 9.7, 0.05% (wt/vol) NaN3, pH 7.4
was used for the coating procedure. The next day the assay
was performed at room temperature (24°C). The wells were
washed twice with 200 ml aliquots of washing buffer con-
sisting of 0.9% NaCl and 0.05% (vol/vol) Tween 20.
Step 2. Aliquots of 200 ml of urine samples diluted 1:5
and seven calibrator samples from The Bindings Site with
human IgM-concentrations between 10 mg/liter and 10
mg/liter, and one blank mixture were incubated in the wells
for one hour. A dilution buffer of 0.137 M NaCl, 0.008 M
Na2HPO4, 0.0027 M KCl, 0.0015 M KH2PO4, 0.02% (wt/vol)
NaN3, 0.01% merthiolate, 0.05% (vol/vol) Tween 20, 0.2%
bovine serum albumin was used for the incubation. The
wells were subsequently washed twice with 200 ml aliquots
of washing buffer.
Step 3. Aliquots of 200 ml of a solution of alkaline
phosphatase conjugated goat anti-human IgM (m-chain
specific) affinity isolated antibody (Sigma, St. Louis, MO,
USA), diluted 1:40,000 in incubation buffer, were then
added to the wells. After incubation for one hour, the wells
were washed twice with 200 ml aliquots of washing buffer.
Step 4. Aliquots of 200 ml of a solution of paraphe-
nylphosphate (1 g/liter) in substrate buffer of 1.0 M dieth-
anolamine, pH 9.8 and 0.0005 M MgCl2 and 0.02% (wt/vol)
NaN3 were then added to the wells. The absorbance of each
well was read at 405 nm with a spectrophotometer (Multi-
skan Plus; Labsystems, Helsinki, Finland) after one hour.
Samples were analyzed in duplicate. The standard curve
obtained at each plate was used to calculate the IgM
concentrations in the urine samples.
Specificity. The curve obtained by serial dilutions of urine
was parallel to the standard curve, indicating that the
antigen measured was IgM. Concentrations in incubation
buffer of up to 200 mg/liter of IgG subclasses 1, 2, 3, and 4
or up to 1000 mg/liter of albumin did not produce any
significant color reactions.
Sensitivity. The sensitivity of the assay was 1 mg/liter
defined as the minimal concentration of IgM that produces
an absorbance greater than two SDs of the blank readings.
Precision. The intraassay coefficient of variation for urine
samples was 4.6% and the interassay variation was 10.9%.
Recovery. The recovery of addition of known amounts of
IgM to normal urine was 93 to 106%.
Calculations
The SI was calculated according to the formula [1, 17]:
SI 5
UHMWprotein
SHMWprotein
3
SAlb
UAlb
where HMW is high molecular weight.
The albumin creatinine index (ACI; mg/mmol), defined
as ratio of UAlb (mg/liter) to UCr (mmol/liter) was used to
estimate the degree of albuminuria [18].
Statistical methods
The data in the Tables are given as medians followed by
the ranges. The Kruskall Wallis test was used for analysis of
variance and post hoc Mann-Whitney test was used for
multiple comparisons. Correlations were tested with Spear-
man correlation coefficient test. P , 0.01 was selected as
the level of significance. For the statistical calculations we
used the detection limit for urine a2M (5 1.6 mg/liter) as
the arbitrary value for urine concentrations of a2M below
the detection limit.
RESULTS
The individual values of IgM SI, a2M SI, and IgG SI for
patient with different types of glomerulonephritis are
shown in Figures 1, 2 and 3, respectively.
The median values in minimal change nephropathy
group of both IgM SI and a2M SI were significantly lower
than the corresponding median values for all other groups.
The median values of IgM SI and a2M SI were signifi-
cantly higher for patients with crescentic necrotizing glo-
merulonephritis than for patients in all the other diagnosis
groups.
The median IgG SI for patients with minimal change
nephropathy differed significantly from the median IgG SI
for patients with diabetic nephropathy and crescentic ne-
crotizing glomerulonephritis, but not from the median IgG
SI for any of the other patient groups. The median IgG SI
for patients with crescentic necrotizing glomerulonephritis
was significantly higher than the corresponding values for
all other patient groups except that for diabetic nephropa-
thy. There was also a significant difference between the
median IgG SI for patients with diabetic nephropathy and
that for patients with IgA nephropathy, membranous glo-
merulonephritis, and mesangial proliferative glomerulone-
phritis.
All three types of SI (a2M SI, IgM SI, and IgG SI)
correlated positively (P , 0.01) to SCr (rho 0.349, 0.545 and
0.654, respectively). The correlation is exemplified in Fig-
ure 4 where the IgG SI values are shown against the SCr.
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The mean SCr level was higher (P , 0.01) in patients with
necrotizing glomerulonephritis than in all other patient
groups, and lower (P , 0.01) in minimal change nephrop-
athy than in patients with diabetic nephropathy, nephro-
sclerosis, diffuse proliferative glomerulonephritis, and ne-
crotizing glomerulonephritis.
DISCUSSION
The results of the present investigation strongly indicate
that the a2M SI and IgM SI can be used to effectively
distinguish two types of glomerular disorders from all the
other six glomerular diseases. The highly selective protein-
uria observed for minimal change nephropathy using these
two types of SI agrees with the previous results obtained
using the IgG SI [1, 17]. However, we found that the
practical clinical utility of IgG SI was low, whereas the a2M
SI and IgM SI were significantly better differential diag-
nostic markers with little overlap between minimal change
nephropathy and the other investigated glomerular dis-
eases (Figs. 1 and 2). The superiority of SI measured using
a2M compared to that using IgG in determine the selec-
tivity of proteinuria has been alleged before by MacLean
and Robson [19].
Furthermore, we have found that the a2M SI and IgM SI
could be used to efficiently differentiate crescentic necro-
tizing glomerulonephritis from the other six types of glo-
merular disease by demonstrating the low selectivity of the
proteinuria accompanying this disorder (Figs. 1 and 2).
Once more, the IgG SI was considerably less efficient for
this differential diagnostic purpose.
The pathophysiology of minimal change nephropathy has
not been unequivocally determined, but available evidence
suggests an electrostatic defect in the glomerular basement
membrane to be crucial in the induction of proteinuria [20].
In steroid responsive minimal change nephropathy a loss of
anionic charge of glomerular basement membrane has
been reported [21] and IgG SI has been shown to be a good
predictor of steroid responsiveness in this disease [22].
A loss of the negative charge of the glomerular capillary
wall was also observed in patients with IgA nephropathy
[23]; those with selective proteinuria tend to have a better
outcome [24] and a higher steroid/cyclophosphamide re-
sponsiveness [25] than those with non-selective type of
proteinuria. Generally, it seems that a glomerular disorder
with a high degree of selectivity of the accompanying
proteinuria before treatment responds best to steroid ther-
apy, irrespective of the histological finding.
Early in the course of diabetic glomerular disease, selec-
tive proteinuria in both micro- and macroalbuminuric
stages is seen [26]. This type of proteinuria might be
associated with changes in the heparan sulphate content of
the glomerular basement membrane [27]. As the disease
progresses, proteinuria becomes more nonselective [28,
29].
Determination of SI has the advantage of reflecting the
overall permeability of the active nephrons in comparison
Fig. 1. The individual values and medians of
IgM selectivity indices in different glomerular
diseases. The values of the selectivity indexes
are shown on a logarithmic scale.
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to a histological examination of a renal biopsy, because a
biopsy specimen represents only a small number of glomer-
uli. Lesions in focal segmental glomerulosclerosis are, by
definition, localized and only affect certain nephrons. Thus,
examination of a biopsy specimen from a patient with this
disorder may therefore indicate the presence of minimal
change nephropathy rather than focal glomerular sclerosis.
A low SI reflects a condition in which all functional
nephrons only allow the passage of relatively small quanti-
ties of high molecular weight proteins like IgG or a2M into
the urine in comparison to albumin [30]. Such findings
indicate that the proteinuria is a consequence of a charge-
selective defect rather than of a size-selective disorder,
irrespective of the histopathological picture. This might
explain why Laurent et al found that IgG SI correlated
better to the steroid responsiveness of patients with lipoid
nephrosis than to the histopathological morphology of their
needle kidney biopsies [30], and why Abdurrahman found a
considerable overlap in the values of IgG SI in patients with
minimal and non-minimal change nephrotic syndromes
[31].
The IgG SI has been shown to provide a mean to
separate steroid-sensitive children with nephrotic syn-
drome from those who are not steroid sensitive. The latter
group had a moderately selective proteinuria of the “dog’s
leg” type [32]. In the present study we did not investigate
the steroid sensitivity of patients with nephrotic syndrome,
but rather, the value of the SI in predicting the histological
diagnoses. The “dog’s leg” type of proteinuria was not
connected to any of the histologic groups studied.
Using a selectivity index may be of great interest for the
clinician because patients with focal segmental glomerulo-
sclerosis can be separated from those with minimal change
nephropathy. However, the number of patients with biopsy-
verified focal segmental glomerulosclerosis was low in our
investigated population, and thus not sufficient to perform
an appropriate statistical analysis. Therefore, we have
chosen not to include this group in the study and to only
investigate patients with minimal change nephropathy.
Further studies comparing the two groups are currently in
progress.
Determinations of SI for patients with crescentic necro-
tizing glomerulonephritis, to our knowledge, have not been
performed previously. This disease is characterized by
segmental or diffuse necrotizing glomerular lesions and
extensive destruction of glomerular basement membrane
[33].
We have found that all three types of SI were signifi-
cantly increased in this disease compared to the corre-
sponding SI for all the other glomerular diseases, with the
exception of IgG SI in diabetic nephropathy.
The theoretical concept of macromolecular movement
across the glomerular capillary wall is based on the hydro-
dynamic theory of hindered solute transport through wa-
terfilled pores [34]. Macromolecules, the size of albumin or
greater, are normally transported through the large pores
Fig. 2. The individual values and medians of
a2-macroglobulin selectivity indices in different
glomerular diseases. The values of the
selectivity indices are shown on a logarithmic
scale; however, the results of a2M SI in
nephrosclerosis group were omitted due to the
small number of samples.
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of the glomerular basement membrane whereas very large
macromolecules such as IgM or a2M are virtually unable to
pass the glomerular filter. Increased density of large pores
leads to increased permeability for albumin and IgG but
not for IgM or a2M. Thus, increased permeation of the two
latter proteins would indicate existence of a third popula-
tion of pores, the size of which would allow the passage of
very large macromolecules, and probably even red blood
cells. The existence of such slits has been postulated [9].
The intact glomerular capillaries, however, exhibit sporadic
“physiological membrane defects” large enough to allow
transport of red cells. These clefts are normally sealed by a
repairing apparatus consisting of cellular elements, clotting
factors, and plasma proteins such as orosomucoid [9]. An
increased transport of very large proteins such as a2M or
IgM that we found in most of the glomerular diseases, but
particularly in crescentic necrotizing glomerulonephritis,
brings about speculations of unsealing of these large clefts
and/or increased density of these defects in the glomerular
membrane, since an increased number of large pores alone
cannot explain the origin of IgM or a2M in the urine of
patients with glomerular diseases.
The findings of this study could also be explained in view
of the “log-normal” pore distribution theory, where the
GBM is perforated by a population of cylindrical pores of
continuous log-normal distribution of radii [35]. The lesser
value of the IgM SI compared to the a2M SI is consistent
with the hypothesis that pore density declines with pore size
[8, 36].
The fact that all three types of SI correlated to the
serum creatinine level supports the assumption that
increased number of large defects in the glomerular
membrane accompanies the increasing glomerular dam-
age. However, there is no simple interdependence be-
tween the selectivity of the proteinuria, the creatinine
level and the renal biopsy-based morphological diag-
noses. For example, although the a2M SI and IgM SI can
be used to almost completely distinguish minimal change
Fig. 3. The individual values and medians of
IgG selectivity indices in different glomerular
diseases. The values of the selectivity indices
are shown on a logarithmic scale.
Fig. 4. Correlation between the IgG selectivity index and serum creati-
nine in 199 patients with various glomerular diseases.
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nephropathy from all the other six types of glomerular
disorders, the serum creatinine level did not differ
between this disorder on one hand, and IgA nephropa-
thy, membranous glomerulonephritis, and mesangial
proliferative glomerulonephritis on the other hand. Fur-
thermore, none of the three types of SI differed between
mesangial proliferative glomerulonephritis and diffuse
proliferative glomerulonephritis or between membra-
nous glomerulonephritis and nephrosclerosis, although
the creatinine level differed.
An important feature of the selectivity index as defined
by Cameron and White is that it only requires the measure-
ment of two proteins in urine and serum, since it represents
a comparative clearance, and consequently the total urinary
output does not have to be determined with its inherent
risk of error in urine collection [1, 30].
The choice between a2M SI and IgM SI is often a matter
of practicality. The single radial immunodiffusion test used
for determination of a2M concentrations is time consuming
and has a relatively low sensitivity. The enzyme-linked
immunosorbent assay used for measurements of the IgM
concentrations has the advantage of being much faster and
its sensitivity is high. The method is, however, difficult to
automate and its cost is high when performed for just a few
specimens at time. A fully automatic turbidimetric test for
a2M is now being tested at our laboratory. This will allow
fast and inexpensive determinations of the protein’s urine
concentrations. However, the sensitivity of the method
remains relatively low.
Based on the present observations, we suggest that the
a2M SI and the IgM SI could be highly useful in the
characterization of glomerular disorders and might replace
the IgG SI for this purpose. The SI might serve as an
important aid to an accurate diagnosis, especially when the
kidney biopsy cannot be performed or does not provide
adequate diagnostic information.
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